title: [Treatment of cardiogenic shock: what is proven?].
abstract: This review will address the pathophysiology, incidence, current outcome and treatment options of patients with cardiogenic shock complicating acute myocardial infarction. The major focus will be on the current evidence based on randomized clinical trials and the current guideline recommendations for the treatment of cardiogenic shock.
authors.affiliation: Klinik für Innere Medizin/Kardiologie - Universität Leipzig - Herzzentrum.
authors.forename: H
authors.initials: H
authors.lastname: Thiele
mesh_terms: D003131:Combined Modality Therapy; D061345:Early Medical Intervention; D019317:Evidence-Based Medicine; D017052:Hospital Mortality; D006801:Humans; D019344:Lactic Acid / Q000097:blood; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D009204:Myocardial Revascularization; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012770:Shock, Cardiogenic / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D013318:Stroke Volume / Q000502:physiology; D015996:Survival Rate; D014661:Vasoconstriction / Q000502:physiology; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy
chemical_list: D019344:Lactic Acid